famotidine has been researched along with Uremia in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gladziwa, U | 1 |
| Klotz, U | 1 |
| Arik, N | 1 |
| Arinsoy, T | 1 |
| Sayín, M | 1 |
| Taşdemir, I | 1 |
| Yasavul, U | 1 |
| Turgan, C | 1 |
| Caglar, S | 1 |
2 other studies available for famotidine and Uremia
| Article | Year |
|---|---|
Adenylate cyclase of gastric mucosa in patients with chronic renal failure.
Topics: Adenylyl Cyclases; Anti-Ulcer Agents; Cyclic AMP; Famotidine; Female; Gastric Mucosa; Gastrins; Heli | 1996 |
Famotidine reduces serum parathyroid hormone levels in uremic patients.
Topics: Alkaline Phosphatase; Calcium; Famotidine; Humans; Hyperparathyroidism; Parathyroid Hormone; Phospha | 1991 |